Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Questcor Pays $135 Million to Acquire Rights to a Competitor’s Drug
Questcor Pays $135 Million to Acquire Rights to a Competitor’s Drug
Questcor Pays $135 Million to Acquire Rights to a Competitor’s Drug
Submitted by
admin
on June 15, 2013 - 1:13pm
Source:
NY Times
News Tags:
Questcor Pharmaceuticals
Synacthen
Novartis
H.P. Acthar Gel
Headline:
Questcor Pays $135 Million to Acquire Rights to a Competitor’s Drug
Do Not Allow Advertisers to Use My Personal information
